Clinical R&D outsourcing needs and models have evolved over the last few years. Many biopharma companies are transitioning to a function-driven sourcing model where we can have a set of fit-for-purpose preferred suppliers to bring in flexibility and agility. Challenges in sourcing needs, pros and cons of different sourcing models will be discussed.